Icon’s impressive capabilities have attracted large pharmaceutical clients, including a preferred partnership with Pfizer. Historically, Icon's revenue heavily relied on Pfizer, its largest customer, ...
Icon reported solid second-quarter results highlighted by revenue exceeding $2 billion, representing an increase of 4% from the prior-year period. We have raised our fair value estimate to $243 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback